发明名称 |
Treatment regimen for N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors |
摘要 |
The present invention relates to methods and compositions for treating diseases. More specifically, the present invention relates to the administration of multiple drugs as part of a treatment of disease. Specific embodiments of the invention relate to a treatment regimen for neuroblastomas and other N-MYC, c-MYC, and L-MYC amplified and overexpressed tumors, comprising administering multiple therapeutic compounds like DFMO, SAM486A, a verinoid and a cytotoxic drug and placing the patient on a low polyamine diet and/or providing the patient with a polyamine limiting dietary supplement. |
申请公布号 |
US9072778(B2) |
申请公布日期 |
2015.07.07 |
申请号 |
US200612158661 |
申请日期 |
2006.12.20 |
申请人 |
UNIVERSITY OF HAWAII |
发明人 |
Bachmann Andre S. |
分类号 |
A61K31/198;A61K31/365;A61K31/203;A61K45/06;A61K31/167 |
主分类号 |
A61K31/198 |
代理机构 |
Davis Wright Tremaine LLP |
代理人 |
Davis Wright Tremaine LLP |
主权项 |
1. A method of treating N-MYC amplified and overexpressed tumors in a mammal, comprising: administering to said mammal a composition comprising therapeutically effective amounts of alpha-difluoromethylornithine (DFMO) and etoposide, wherein administration of the composition results in inhibition of abnormal cell proliferation, wherein the N-MYC amplified and overexpressed tumor is a neuroblastoma tumor. |
地址 |
Honolulu HI US |